| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |